Does Rallies show Form 4 insider transactions for ARQT?

Yes. Rallies tracks ARQT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ARQT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ARQT. It does not provide personalized investment advice.

ARQT (Arcutis Biotherapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Arcutis Biotherapeutics, Inc. Common Stock (ARQT) is a publicly traded Healthcare sector company. As of October 9, 2026, ARQT trades at $25.19 with a market cap of $3.04B and a P/E ratio of 114.34. ARQT moved +1.06% today. Year to date, ARQT is -15.55%; over the trailing twelve months it is +15.30%. Its 52-week range spans $11.75 to $31.77. Analyst consensus is strong buy with an average price target of $36.67. Rallies surfaces ARQT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ARQT stock inside the company?

Rallies tracks ARQT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

ARQT Key Metrics

Key financial metrics for ARQT
Metric	Value
Price	$25.19
Market Cap	$3.04B
P/E Ratio	114.34
EPS	$0.22
Dividend Yield	0.00%
52-Week High	$31.77
52-Week Low	$11.75
Volume	133.29K
Avg Volume	0
Revenue (TTM)	$463.98M
Net Income	$28.52M
Gross Margin	91.14%

ARQT Analyst Consensus

6 analysts cover ARQT: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $36.67.

Common questions about ARQT

Who is trading ARQT stock inside the company?: Rallies tracks ARQT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for ARQT?: Yes. Rallies tracks ARQT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ARQT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ARQT. It does not provide personalized investment advice.